Gaucher Disease (GBA), Enzyme Activity in Leukocytes
Use to diagnose Gaucher disease only; not indicated for carrier screening.
New York DOH Approval Status
Yellow (ACD), Lavender (K2EDTA), Lavender (K3EDTA), or Green (Sodium Heparin).
Transport 3 mL whole blood. (Min: 1 mL)
Grossly hemolyzed specimens.
Additional information is required: Clinical Indication for testing.
Ambient: Unacceptable; Refrigerated: 3 days; Frozen: Unacceptable
4.6 - 12.0 nmol hydrolyzed/hr/mg protein
Refer to report.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
|Component Test Code*||Component Chart Name||LOINC|
|2014460||Gaucher GBA Activity Leukocytes Interp||48767-8|
|2014461||Gaucher GBA Activity Leukocytes||32540-7|